Visualization of Lymph Nodes and Lymphatic Vessels During Lymphatic Mapping for cervical and uterine tumors (1.25 mg/mL solution):
Inject SPY AGENT GREEN approximately 45 minutes prior to surgery to allow indocyanine green to collect in the biliary anatomy.Īdditional doses may be administered to obtain additional imaging sequences during the procedure, however, do not exceed a total dose of 2 mg/kg. The recommended single intravenous dose in adults and pediatric patients aged 12 to 17 years is 2.5 mg SPY AGENT GREEN. Visualization of Extrahepatic Biliary Ducts (2.5 mg/mL solution): The recommended single intravenous dose in adults for visualization of perfusion in extremities through the skin for plastic, micro, and reconstructive surgeries is 3.75 mg to 10 mg.Īdditional doses may be administered to obtain additional imaging sequences during the procedure, however, do not exceed a total dose of 2 mg/kg. The recommended single intravenous dose in adults and pediatric patients one month and older for a surgical procedure is 1.25 mg to 5 mg. If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.Visualization of Vessels, Blood Flow and Tissue Perfusion (2.5 mg/mL solution): The use of the eHealthMe site and its content is at your own risk. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. Different individuals may respond to medication in different ways. Our phase IV clinical studies alone cannot establish cause-effect relationship. 
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.ĭISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. Our analysis results are available to researchers, health care professionals, patients ( testimonials), and software developers ( open API). Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. We study millions of patients and 5,000 more each day. With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials.
0 kommentar(er)
